FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

320 letters match. Newest first.

  1. Orphic Nutrition

    FDA warned Orphic Nutrition that its supplement capsules and gummies are unapproved new drugs because website claims say they treat diseases.

    High risk
  2. Exela Pharma Sciences LLC

    FDA warns Exela Pharma Sciences that poor adverse event reporting left compounded drugs unapproved and with labeling violations.

    Medium
  3. Trinity Natural Health & Pain Management, Inc.

    FDA and FTC warned Trinity Natural Health over selling an unapproved 'COVID-19 Formula' with claims to prevent or treat COVID-19.

    High risk
  4. About Mineral

    FDA and FTC warn About Mineral that its Puriton skin products are unapproved drugs with misleading COVID-19 claims.

    High risk
  5. Natural Adventure, LLC

    Natural Adventure LLC sold unapproved Purity sanitizer and essential oil products with COVID-19 treatment claims, FDA says.

    High risk
  6. PYRLess Group, LLC dba Dr. Fitt

    FDA and FTC warned PYRLess Group (Dr. Fitt) for selling vitamin and iodine supplements claimed to prevent or treat COVID-19 without approval.

    High risk
  7. Honest Globe, Inc.

    FDA cited Honest Globe for manufacturing-quality failures and for selling unapproved CBD pain-relief drugs.

    High risk
  8. Ravenscroft Apothecary, Inc. DBA Ravenscroft Escentials

    FDA warns Ravenscroft Escentials over unapproved COVID-19 claims for aromatherapy products.

    High risk
  9. Mercola.com, LLC

    FDA warned Mercola.com that website claims made its vitamin C, D3, and quercetin products unapproved COVID-19 drugs.

    High risk
  10. Native Remedies dba Silver Star Brands

    FDA warned Native Remedies that MindSoothe Drops and Capsules are unapproved, misbranded drugs promoted for depression and sleep problems.

    High risk
  11. Enlifta, LLC

    FDA warned Enlifta that it sells unapproved new drugs for depression and anxiety through its website and Amazon.

    High risk
  12. Evolved Ayurvedic Discoveries, Inc./BioCBDPlus

    FDA warned BioCBDPlus that its CBD topicals and vape are unapproved new drugs sold with disease and COVID-19 claims.

    High risk
  13. Clarke Pharmaceutical Manufacturing, Inc.

    FDA warned Clarke Pharmaceutical Manufacturing that it sells five unapproved drugs online, including a vitamin product claimed to prevent and treat COVID-19.

    High risk
  14. rx2go.com

    FDA warned rx2go.com for selling unapproved, misbranded hydroxychloroquine and other drugs online with COVID-19 claims.

    High risk
  15. sandra-pharma.is

    FDA warned sandra-pharma.is for selling unapproved hydroxychloroquine and azithromycin online as a COVID-19 treatment.

    High risk
  16. buy-pharma.md

    FDA warned buy-pharma.md that its website sells unapproved prescription drugs, including azithromycin and hydroxychloroquine, with COVID-19 claims.

    High risk
  17. American Global Health Group, LLC

    FDA warned American Global Health Group that AloeCure website and Facebook claims make its products unapproved new drugs and misbranded.

    Low
  18. Entia Biosciences, Inc

    FDA warned Entia Biosciences over mushroom supplement website claims that made the products unapproved, misbranded drugs.

    Low
  19. Allimax Us

    Allimax US sold allicin products as unapproved COVID-19 drugs with unlawful labeling.

    High risk
  20. Coco's Holistic Specialties & Apothecary

    FDA warned Coco's Holistic Specialties & Apothecary that its 4-Thieves teas are unapproved, misbranded drugs sold with COVID-19 treatment claims.

    High risk